286 related articles for article (PubMed ID: 38318166)
21. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
[TBL] [Abstract][Full Text] [Related]
22. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
Reche PA
Front Immunol; 2020; 11():586984. PubMed ID: 33178220
[TBL] [Abstract][Full Text] [Related]
23. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
[TBL] [Abstract][Full Text] [Related]
24. Preclinical Development of a Novel Epitope-based DNA Vaccine Candidate against SARS-CoV-2 and Evaluation of Immunogenicity in BALB/c Mice.
Khalid K; Lim HX; Anwar A; Tan SH; Hwang JS; Ong SK; Poh CL
AAPS PharmSciTech; 2024 Mar; 25(3):60. PubMed ID: 38472523
[TBL] [Abstract][Full Text] [Related]
25. A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta.
Carter B; Huang P; Liu G; Liang Y; Lin PJC; Peng BH; McKay LGA; Dimitrakakis A; Hsu J; Tat V; Saenkham-Huntsinger P; Chen J; Kaseke C; Gaiha GD; Xu Q; Griffiths A; Tam YK; Tseng CK; Gifford DK
Front Immunol; 2023; 14():1135815. PubMed ID: 36969239
[TBL] [Abstract][Full Text] [Related]
26. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
Elife; 2022 Aug; 11():. PubMed ID: 36004719
[TBL] [Abstract][Full Text] [Related]
27. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
Front Immunol; 2021; 12():692937. PubMed ID: 34497604
[TBL] [Abstract][Full Text] [Related]
28. Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants.
Ballesteros-Sanabria L; Pelaez-Prestel HF; Ras-Carmona A; Reche PA
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625733
[TBL] [Abstract][Full Text] [Related]
29.
Isaeva OI; Ketelaars SLC; Kvistborg P
Front Immunol; 2022; 13():891524. PubMed ID: 35572563
[TBL] [Abstract][Full Text] [Related]
30. A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus.
Kibria KMK; Faruque MO; Islam MSB; Ullah H; Mahmud S; Miah M; Saleh AA
Appl Microbiol Biotechnol; 2022 Jun; 106(11):4091-4114. PubMed ID: 35612630
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.
Tarke A; Coelho CH; Zhang Z; Dan JM; Yu ED; Methot N; Bloom NI; Goodwin B; Phillips E; Mallal S; Sidney J; Filaci G; Weiskopf D; da Silva Antunes R; Crotty S; Grifoni A; Sette A
Cell; 2022 Mar; 185(5):847-859.e11. PubMed ID: 35139340
[TBL] [Abstract][Full Text] [Related]
32. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
[TBL] [Abstract][Full Text] [Related]
33. Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8
Jin X; Ding Y; Sun S; Wang X; Zhou Z; Liu X; Li M; Chen X; Shen A; Wu Y; Liu B; Zhang J; Li J; Yang Y; Qiu H; Shen C; He Y; Zhao G
Cell Mol Immunol; 2021 Dec; 18(12):2588-2608. PubMed ID: 34728796
[TBL] [Abstract][Full Text] [Related]
34. Identification and assessment of TCR-T cells targeting an epitope conserved in SARS-CoV-2 variants for the treatment of COVID-19.
Ma Y; Liu F; Li B; Peng K; Zhou H; Xu Y; Qiao D; Deng L; Tian G; Nielsen M; Wang M
Int Immunopharmacol; 2022 Nov; 112():109283. PubMed ID: 36201943
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ
Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696
[TBL] [Abstract][Full Text] [Related]
36. Development of multi-epitope peptide-based vaccines against SARS-CoV-2.
Lim HX; Lim J; Jazayeri SD; Poppema S; Poh CL
Biomed J; 2021 Mar; 44(1):18-30. PubMed ID: 33727051
[TBL] [Abstract][Full Text] [Related]
37. Structure-guided TÂ cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.
Nathan A; Rossin EJ; Kaseke C; Park RJ; Khatri A; Koundakjian D; Urbach JM; Singh NK; Bashirova A; Tano-Menka R; Senjobe F; Waring MT; Piechocka-Trocha A; Garcia-Beltran WF; Iafrate AJ; Naranbhai V; Carrington M; Walker BD; Gaiha GD
Cell; 2021 Aug; 184(17):4401-4413.e10. PubMed ID: 34265281
[TBL] [Abstract][Full Text] [Related]
38. Identification of promising CD8 and CD4 T cell epitopes for peptide vaccine formulation against SARS-CoV-2.
Chakraborty S; Deb B; Nath D; Monoswita D
Arch Microbiol; 2022 Apr; 204(5):242. PubMed ID: 35380253
[TBL] [Abstract][Full Text] [Related]
39. Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
Liu MQ; Jiang RD; Guo J; Chen Y; Yang DS; Wang X; Lin HF; Li A; Li B; Hu B; Wang ZJ; Yang XL; Shi ZL
J Virol; 2022 Apr; 96(8):e0016922. PubMed ID: 35343762
[TBL] [Abstract][Full Text] [Related]
40. Suboptimal SARS-CoV-2-specific CD8
Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]